Current Pharmacology Reports, Journal Year: 2024, Volume and Issue: unknown
Published: Sept. 4, 2024
Language: Английский
Current Pharmacology Reports, Journal Year: 2024, Volume and Issue: unknown
Published: Sept. 4, 2024
Language: Английский
Molecules, Journal Year: 2024, Volume and Issue: 29(5), P. 1128 - 1128
Published: March 2, 2024
Taxus mairei (Lemée and H.Lév.) S.Y.Hu, indigenous to the southern regions of China, is an evergreen tree belonging genus Taxaceae family. Owing its content various bioactive compounds, it exhibits multiple pharmacological activities has been widely applied in clinical medicine. This article comprehensively discusses current state cultivation, chemical constituents, applications pharmaceutical field, challenges faced by T. mairei. The paper begins detailing ecological distribution mairei, aiming provide in-depth understanding origin cultivation overview. In terms composition, thoroughly summarizes extracts monomeric components unveiling their elucidating mechanisms action based on latest scientific research, as well potential lead compounds new drug development. also addresses such difficulties extracting synthesizing active need for sustainable utilization strategies. summary, a rare species important biodiversity conservation demonstrates significant research application development disease treatment.
Language: Английский
Citations
4In Silico Pharmacology, Journal Year: 2025, Volume and Issue: 13(1)
Published: March 6, 2025
Language: Английский
Citations
0South African Journal of Botany, Journal Year: 2025, Volume and Issue: 181, P. 315 - 338
Published: April 25, 2025
Language: Английский
Citations
0Pharmaciana, Journal Year: 2024, Volume and Issue: 14(1), P. 20 - 20
Published: March 29, 2024
Parkinson's disease is a chronic neurological illness that may be caused by decrease in dopaminergic neurons the brain. Myristicin, eugenol, and flavonoids, which are bioactive compounds nutmeg ( Myristica fragrans Houtt.), able to treat disease. The goal of this study was find out antiparkinsonian effect haloperidol-induced mice. Induction with haloperidol carried intraperitoneally for 7 consecutive days. Treatment uses three different doses (5, 10, 20 mg/kg) days orally. Behavioral testing using Rotarod test cylinder test. results showed at dose mg/kg show significant improvement (P < 0.05) motor condition animals induced haloperidol.
Language: Английский
Citations
0Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: June 6, 2024
Language: Английский
Citations
0Journal of Functional Foods, Journal Year: 2024, Volume and Issue: 119, P. 106322 - 106322
Published: June 25, 2024
Language: Английский
Citations
0Published: Jan. 1, 2024
Language: Английский
Citations
0Current Pharmacology Reports, Journal Year: 2024, Volume and Issue: unknown
Published: Sept. 4, 2024
Language: Английский
Citations
0